XML 46 R35.htm IDEA: XBRL DOCUMENT
v3.19.2

Earnings Per Share (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2019
Earnings Per Share [Abstract] |
Calculations of Earnings Per Share | The calculations of earnings per share are as follows:
| Three Months Ended June 30, |  | Six Months Ended June 30,
($ and shares in millions except per share amounts) | 2019 |  | 2018 |  | 2019 |  | 2018
Net income attributable to Merck & Co., Inc. | $ | 2,670 |  |  | $ | 1,707 |  |  | $ | 5,585 |  |  | $ | 2,443 |
Average common shares outstanding | 2,574 |  |  | 2,683 |  |  | 2,579 |  |  | 2,689 |
Common shares issuable (1) | 14 |  |  | 13 |  |  | 17 |  |  | 13 |
Average common shares outstanding assuming dilution | 2,588 |  |  | 2,696 |  |  | 2,596 |  |  | 2,702 |
Basic earnings per common share attributable to Merck & Co., Inc. common shareholders | $ | 1.04 |  |  | $ | 0.64 |  |  | $ | 2.17 |  |  | $ | 0.91 |
Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders | $ | 1.03 |  |  | $ | 0.63 |  |  | $ | 2.15 |  |  | $ | 0.90 |
(1) Issuable primarily under share-based compensation plans.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration